491 related articles for article (PubMed ID: 17192274)
1. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
[TBL] [Abstract][Full Text] [Related]
2. Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase.
Liang F; Luo Y; Dong Y; Walls CD; Liang J; Jiang HY; Sanford JR; Wek RC; Zhang ZY
J Biol Chem; 2008 Apr; 283(16):10339-46. PubMed ID: 18268019
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.
Walls CD; Iliuk A; Bai Y; Wang M; Tao WA; Zhang ZY
Mol Cell Proteomics; 2013 Dec; 12(12):3759-77. PubMed ID: 24030100
[TBL] [Abstract][Full Text] [Related]
4. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
[TBL] [Abstract][Full Text] [Related]
5. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
6. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
Luo Y; Liang F; Zhang ZY
Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
[TBL] [Abstract][Full Text] [Related]
7. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase.
Kunte DP; Wali RK; Koetsier JL; Roy HK
Mol Cancer Ther; 2008 Jul; 7(7):1797-806. PubMed ID: 18644992
[TBL] [Abstract][Full Text] [Related]
10. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
Achiwa H; Lazo JS
Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
[TBL] [Abstract][Full Text] [Related]
11. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
Senda Y; Murata-Kamiya N; Hatakeyama M
Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the csk gene suppresses tumor metastasis in vivo.
Nakagawa T; Tanaka S; Suzuki H; Takayanagi H; Miyazaki T; Nakamura K; Tsuruo T
Int J Cancer; 2000 Nov; 88(3):384-91. PubMed ID: 11054667
[TBL] [Abstract][Full Text] [Related]
13. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of Csk and CHK kinases in breast cancer cells.
Bougeret C; Jiang S; Keydar I; Avraham H
J Biol Chem; 2001 Sep; 276(36):33711-20. PubMed ID: 11445575
[TBL] [Abstract][Full Text] [Related]
15. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
González-Sánchez A; Jaraíz-Rodríguez M; Domínguez-Prieto M; Herrero-González S; Medina JM; Tabernero A
Oncotarget; 2016 Aug; 7(31):49819-49833. PubMed ID: 27391443
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling.
Csoboz B; Gombos I; Tatrai E; Tovari J; Kiss AL; Horvath I; Vigh L
Cell Commun Signal; 2018 Aug; 16(1):51. PubMed ID: 30157875
[TBL] [Abstract][Full Text] [Related]
17. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
18. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization.
Sirvent A; Bénistant C; Pannequin J; Veracini L; Simon V; Bourgaux JF; Hollande F; Cruzalegui F; Roche S
Oncogene; 2010 Mar; 29(9):1303-15. PubMed ID: 20010872
[TBL] [Abstract][Full Text] [Related]
19. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
[TBL] [Abstract][Full Text] [Related]
20. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
